GCT is delighted to announce that we received the approval to conduct a Phase III epilepsy trial in Bulgaria for our long-term partner, a US pharmaceutical company.
The task was completed in just 50 working days.
Apr 14, 2016
GCT is delighted to announce that we received the approval to conduct a Phase III epilepsy trial in Bulgaria for our long-term partner, a US pharmaceutical company.
The task was completed in just 50 working days.